Respiratory infections are the leading cause of use of general practice services in Australia and in many other countries. Acute respiratory infections are amongst the leading causes of morbidity and mortality in children in low-income settings. They are often managed sub-optimally and are a leading cause of the overuse of antibiotics, suggesting deficiencies in the application of research data to inform clinical decisions.
Our reviews and topics list
Status | Stage |
---|---|
- Acellular vaccines for preventing whooping cough in children
- Acetaminophen (paracetamol) for the common cold in adults
- Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease
- Acupuncture for mumps in children
- Acyclovir for treating varicella in otherwise healthy children and adolescents
- Adverse events in people taking macrolide antibiotics versus placebo for any indication
- Advising patients to increase fluid intake for treating acute respiratory infections
- Amantadine and rimantadine for influenza A in adults
- Amantadine and rimantadine for influenza A in children and the elderly
- Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures
- Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze
- Antibiotics for acute bronchitis
- Antibiotics for acute laryngitis in adults
- Antibiotics for acute otitis media in children
- Antibiotics for acute rhinosinusitis in adults
- Antibiotics for bronchiolitis in children under two years of age
- Antibiotics for community-acquired lower respiratory tract infections secondary to in children
- Antibiotics for community-acquired pneumonia in adult outpatients
- Antibiotics for community-acquired pneumonia in children
- Antibiotics for hospital-acquired pneumonia in neonates and children
- Antibiotics for preventing complications in children with measles
- Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under
- Antibiotics for preventing meningococcal infections
- Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age
- Antibiotics for the common cold and acute purulent rhinitis
- Antibiotics for the prevention of acute and chronic suppurative otitis media in children
- Antibiotics for treatment of sore throat in children and adults
- Antibiotics for ventilator-associated pneumonia
- Antibiotics for whooping cough (pertussis)
- Antihistamines for the common cold
- Antiviral agents for infectious mononucleosis (glandular fever)
- Azithromycin for acute lower respiratory tract infections
- Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis
- Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care
- Bronchodilators for bronchiolitis
- Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old
- Chest physiotherapy for pneumonia in adults
- Chest physiotherapy for pneumonia in children
- Chest radiographs for acute lower respiratory tract infections
- Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)
- Chinese medicinal herbs for acute bronchitis
- Chinese medicinal herbs for influenza
- Chinese medicinal herbs for measles
- Chinese medicinal herbs for mumps
- Chinese medicinal herbs for sore throat
- Chinese medicinal herbs for the common cold
- Clinical symptoms and signs for the diagnosis of <I>Mycoplasma pneumoniae</I> in children and adolescents with community-acquired pneumonia
- Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
- Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and <I>Haemophilus influenzae</I> B (HIB)
- Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children
- Continuous positive airway pressure (CPAP) for acute bronchiolitis in children
- Corticosteroids as adjunctive therapy in the treatment of influenza
- Corticosteroids as standalone or add-on treatment for sore throat
- Corticosteroids for acute bacterial meningitis
- Corticosteroids for parasitic eosinophilic meningitis
- Corticosteroids for pneumonia
- Corticosteroids for the common cold
- Decongestants and antihistamines for acute otitis media in children
- Decongestants, antihistamines and nasal irrigation for acute sinusitis in children
- Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting
- Different antibiotic treatments for group A streptococcal pharyngitis
- Echinacea for preventing and treating the common cold
- Efficacy and safety of pertussis vaccination in pregnancy to prevent whooping cough in early infancy
- Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat
- Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
- Epinephrine for bronchiolitis
- Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
- Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections
- extract for acute sinusitis
- Fluid therapy for acute bacterial meningitis
- Garlic for the common cold
- Glucocorticoids for acute viral bronchiolitis in infants and young children
- Glucocorticoids for croup in children
- Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
- Heated, humidified air for the common cold
- Heliox for croup in children
- Heliox inhalation therapy for bronchiolitis in infants
- High-flow nasal cannula therapy for infants with bronchiolitis
- Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
- Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like illness
- Honey for acute cough in children
- Immediate versus delayed versus no antibiotics for respiratory infections
- Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection
- Immunostimulants for preventing respiratory tract infection in children
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions
- Influenza vaccines for preventing acute otitis media in infants and children
- Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
- Interventions to increase influenza vaccination rates of those 60 years and older in the community
- Intranasal ipratropium bromide for the common cold
- Intranasal steroids for acute sinusitis
- Leukotriene inhibitors for bronchiolitis in infants and young children
- Macrolides for diffuse panbronchiolitis
- Magnesium sulphate for treating acute bronchiolitis in children up to two years of age
- Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
- Nasal decongestants in monotherapy for the common cold
- Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months
- Nebulised hypertonic saline solution for acute bronchiolitis in infants
- Nebulized epinephrine for croup in children
- Neuraminidase inhibitors for preventing and treating influenza in adults and children
- Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
- Non-corticosteroid adjuvant therapies for acute bacterial meningitis
- Non-steroidal anti-inflammatory drugs (NSAIDs) for acute sore throat
- Non-steroidal anti-inflammatory drugs for the common cold
- Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media
- Oral (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Oral antihistamine-decongestant-analgesic combinations for the common cold
- oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
- Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
- Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections
- Osmotic therapies added to antibiotics for acute bacterial meningitis
- Over-the-counter (OTC) medications for acute cough in children and adults in community settings
- Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age
- Oxygen therapy for pneumonia in adults
- Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
- Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children
- Parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis
- Pelargonium sidoides extract for treating acute respiratory tract infections
- Physical interventions to interrupt or reduce the spread of respiratory viruses
- Pneumococcal conjugate vaccines for preventing acute otitis media in children
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
- Polysaccharide vaccines for preventing serogroup A meningococcal meningitis
- Positioning for acute respiratory distress in hospitalised infants and children
- Post-exposure passive immunisation for preventing measles
- Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome
- Pre-admission antibiotics for suspected cases of meningococcal disease
- Probiotics for preventing acute otitis media in children
- Probiotics for preventing acute upper respiratory tract infections
- Probiotics for preventing ventilator-associated pneumonia
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
- Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
- Rapid antigen detection test for group A streptococcus in children with pharyngitis
- Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
- Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma
- Routine vitamin A supplementation for the prevention of blindness due to measles infection in children
- Saline nasal irrigation for acute upper respiratory tract infections
- Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation
- Short-course antibiotics for acute otitis media
- Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months
- Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients
- Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
- Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children
- Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age
- Steroids for symptom control in infectious mononucleosis
- Surfactant therapy for bronchiolitis in critically ill infants
- Surgical versus non-surgical management for pleural empyema
- Symptomatic treatment of the cough in whooping cough
- Systemic corticosteroids for acute otitis media in children
- Systemic corticosteroids for acute sinusitis
- Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis
- Topical analgesia for acute otitis media
- Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation
- Vaccines for measles, mumps, rubella, and varicella in children
- Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults
- Vaccines for preventing herpes zoster in older adults
- Vaccines for preventing influenza in healthy adults
- Vaccines for preventing influenza in healthy children
- Vaccines for preventing influenza in the elderly
- Vaccines for preventing pneumococcal infection in adults
- Vaccines for the common cold
- Vitamin A for non-measles pneumonia in children
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
- Vitamin A for treating measles in children
- Vitamin C for preventing and treating pneumonia
- Vitamin C for preventing and treating the common cold
- Vitamin C supplementation for prevention and treatment of pneumonia
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- Vitamin D for preventing acute respiratory infections in children up to five years of age
- Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
- Xylitol for preventing acute otitis media in children up to 12 years of age
- Zinc for prevention and treatment of the common cold
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
- Zinc supplementation for the treatment of measles in children
- Zinc supplements for preventing otitis media
- Acute cough (acute bronchitis) (5)
- Prevention (0)
- Treatment (5)
- Antibiotics (1)
- Bronchodilators (1)
- Other therapies (3)
- Acute rhinosinusitis/sinusitis (5)
- Prevention (0)
- Treatment (5)
- Adverse events (1)
- Bronchiolitis (17)
- Prevention (0)
- Immunoglobulin (0)
- Treatment (17)
- Antibiotics (2)
- Inhalation therapy (5)
- Continuous positive airway pressure (CPAP) for acute bronchiolitis in children
- Heliox inhalation therapy for bronchiolitis in infants
- High-flow nasal cannula therapy for infants with bronchiolitis
- Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age
- Nebulised hypertonic saline solution for acute bronchiolitis in infants
- Other therapies (7)
- Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection
- Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old
- Parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis
- Leukotriene inhibitors for bronchiolitis in infants and young children
- Magnesium sulphate for treating acute bronchiolitis in children up to two years of age
- Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months
- Surfactant therapy for bronchiolitis in critically ill infants
- Bronchodilators (2)
- Steroids (1)
- Prevention (0)
- Chickenpox (varicella zoster) (2)
- Prevention (1)
- Antivirals (0)
- Vaccines (1)
- Treatment (1)
- Antivirals (1)
- Vaccines (0)
- Prevention (1)
- Common cold (coryza) (20)
- Prevention (4)
- Antivirals (0)
- Complementary medicine (3)
- Vaccines (1)
- Treatment (16)
- Antibiotics (1)
- Antivirals (0)
- Complementary medicine (5)
- Other therapies (9)
- Intranasal ipratropium bromide for the common cold
- Acetaminophen (paracetamol) for the common cold in adults
- Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease
- Antihistamines for the common cold
- Nasal decongestants in monotherapy for the common cold
- Heated, humidified air for the common cold
- Non-steroidal anti-inflammatory drugs for the common cold
- Oral antihistamine-decongestant-analgesic combinations for the common cold
- Over-the-counter (OTC) medications for acute cough in children and adults in community settings
- Steroids (1)
- Prevention (4)
- Croup (4)
- Prevention (0)
- Treatment (4)
- Antibiotics (0)
- Antivirals (0)
- Inhalation therapy (3)
- Steroids (1)
- Diagnostic (0)
- Diphtheria (1)
- Epiglottitis (0)
- Prevention (0)
- Treatment (0)
- German measles (rubella) (2)
- Glandular fever (infectious mononucleosis) (2)
- Prevention (0)
- Treatment (2)
- Shingles (herpes zoster) (1)
- Prevention (1)
- Treatment (0)
- Histoplasmosis (0)
- Influenza (20)
- Prevention (13)
- Amantadine and rimantadine (2)
- Neuraminidase inhibitors (2)
- Other interventions (2)
- Overview of prevention interventions (0)
- Vaccines (7)
- Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
- Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and <I>Haemophilus influenzae</I> B (HIB)
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions
- Interventions to increase influenza vaccination rates of those 60 years and older in the community
- Vaccines for preventing influenza in healthy children
- Vaccines for preventing influenza in the elderly
- Vaccines for preventing influenza in healthy adults
- Treatment (7)
- Amantadine and rimantadine (2)
- Neuraminidase inhibitors (2)
- Other interventions (3)
- Overview of treatment interventions (0)
- Prevention (13)
- Laryngitis (1)
- Prevention (0)
- Treatment (1)
- Antibiotics (1)
- Legionnaire's disease (0)
- Measles (6)
- Prevention (3)
- Treatment (3)
- Middle ear infection (acute otitis media) (13)
- Diagnostic (0)
- Prevention (6)
- Antibiotics (1)
- Other therapies (3)
- Vaccines (2)
- Treatment (7)
- Antibiotics (3)
- Other therapies (4)
- Decongestants and antihistamines for acute otitis media in children
- Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children
- Systemic corticosteroids for acute otitis media in children
- Topical analgesia for acute otitis media
- Meningitis (11)
- Diagnosis (1)
- Prevention (3)
- Treatment (7)
- Antibiotics (2)
- Other therapies (3)
- Steroids (2)
- Mumps (3)
- Prevention (1)
- Treatment (2)
- Complementary medicine (2)
- Pleural infections (1)
- Pneumonia (34)
- Diagnosis (1)
- Prevention (9)
- Antibiotics (1)
- Complementary medicine (4)
- Other therapies (1)
- Vaccines (3)
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Vaccines for preventing pneumococcal infection in adults
- Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
- Treatment (24)
- Antibiotics (14)
- Antibiotics for ventilator-associated pneumonia
- Antibiotics for community-acquired pneumonia in adult outpatients
- Antibiotics for hospital-acquired pneumonia in neonates and children
- Antibiotics for community-acquired lower respiratory tract infections secondary to in children
- Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze
- Antibiotics for community-acquired pneumonia in children
- Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
- Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
- Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
- Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients
- Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
- Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months
- Complementary medicine (4)
- Other therapies (6)
- Chest physiotherapy for pneumonia in adults
- Chest physiotherapy for pneumonia in children
- Corticosteroids for pneumonia
- Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
- Oxygen therapy for pneumonia in adults
- Antibiotics (14)
- Respiratory syncytial virus (3)
- Prevention (2)
- Treatment (1)
- SARS (1)
- Prevention (0)
- Treatment (1)
- Sore throat (pharyngitis, tonsillitis) (8)
- Diagnosis (1)
- Prevention (0)
- Treatment (7)
- Antibiotics (3)
- Other therapies (4)
- Undifferentiated acute respiratory infections (30)
- Advising patients to increase fluid intake for treating acute respiratory infections
- Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age
- Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under
- Azithromycin for acute lower respiratory tract infections
- Oral (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children
- Probiotics for preventing acute upper respiratory tract infections
- Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care
- Chest radiographs for acute lower respiratory tract infections
- Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children
- Immediate versus delayed versus no antibiotics for respiratory infections
- Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
- Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections
- Immunostimulants for preventing respiratory tract infection in children
- Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma
- Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
- Saline nasal irrigation for acute upper respiratory tract infections
- Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
- Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections
- Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age
- Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
- Pelargonium sidoides extract for treating acute respiratory tract infections
- Positioning for acute respiratory distress in hospitalised infants and children
- Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department
- Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
- Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
- Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age
- Vitamin D for preventing acute respiratory infections in children up to five years of age
- Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
- Whooping cough (pertussis) (5)
- Prevention (3)
- Vaccines (3)
- Acellular vaccines for preventing whooping cough in children
- Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and <I>Haemophilus influenzae</I> B (HIB)
- Efficacy and safety of pertussis vaccination in pregnancy to prevent whooping cough in early infancy
- Vaccines (3)
- Treatment (2)
- Antibiotics (1)
- Other therapies (1)
- Prevention (3)